Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Vital ChemtechNSE:VITAL +1.77%76 Debt-to-EBITDA is 7.34 as of Mar. 2026, which is 132% above its 10-year median of 3.17. GuruFocus rates NSE:VITAL with a GF Score™ of 76/100 and a GF Value™ of ₹83.08 (Possible Value Trap). The stock has 10 warning signs investors should review. Among 1,243 Chemicals companies, Vital Chemtech ranks worse than 85.2% on this metric.
Debt-to-EBITDA measures a company's ability to pay off its debt.
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
The historical rank and industry rank for Vital Chemtech's Debt-to-EBITDA or its related term are showing as below:
NSE:VITAL'
s Debt-to-EBITDA Range Over the Past 10 Years
Min: 1.53 Med: 3.17 Max: 8.71
Current: 7.67
During the past 7 years, the highest Debt-to-EBITDA Ratio of Vital Chemtech was 8.71. The lowest was 1.53. And the median was 3.17.
NSE:VITAL's Debt-to-EBITDA is ranked worse than 85.2% of 1243
companies
in the Chemicals industry
Industry Median: 2.14
vs NSE:VITAL: 7.67
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.
According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
Vital Chemtech Debt-to-EBITDA Related Terms
Vital Chemtech Debt-to-EBITDA Historical Data
* Premium members only.
The historical data trend for Vital Chemtech's Debt-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:VITAL vs LIN, SHW, ECL: Debt-to-EBITDA Comparison
For the Specialty Chemicals subindustry, Vital Chemtech's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vital Chemtech Debt-to-EBITDA vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Vital Chemtech's Debt-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Vital Chemtech's Debt-to-EBITDA falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data,
the EBITDA data used here is two times the quarterly (Mar. 2026) EBITDA data.
Vital Chemtech (NSE:VITAL) has a Debt-to-EBITDA of 7.34 as of Mar. 2026. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Vital Chemtech. This is 132% above median its historical median of 3.17. Over the past decade, Vital Chemtech's Debt-to-EBITDA has ranged from 1.53 to 8.71. According to the industry distribution chart, Vital Chemtech ranks #1059 out of 1243 companies in the Chemicals industry, placing it in the top 85.2%.
Is Vital Chemtech's Debt-to-EBITDA too high?
Vital Chemtech's current Debt-to-EBITDA of 7.34 is 132% above median its 10-year median of 3.17. Over the past 10 years, this metric has ranged from a low of 1.53 to a high of 8.71. The Chemicals industry median Debt-to-EBITDA is 2.14. Vital Chemtech's value of 7.34 is 243% above this industry median. Based on the distribution chart, Vital Chemtech ranks #1059 out of 1243 companies in the Chemicals industry, which is in the bottom quartile relative to peers. Overall, Vital Chemtech has a GF Score™ of 76/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Vital Chemtech's Debt-to-EBITDA compare to LIN and SHW?
According to the Chemicals industry distribution chart, Vital Chemtech ranks #1059 out of 1243 companies for Debt-to-EBITDA. This places Vital Chemtech in the lower half of its industry. The industry median Debt-to-EBITDA is 2.14. Vital Chemtech's value of 7.34 is 243% above this benchmark. Historically, Vital Chemtech's own Debt-to-EBITDA has ranged from 1.53 to 8.71 over the past decade. While the company's 10-year median is 3.17 vs. the industry median of 2.14, Vital Chemtech has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-EBITDA for a Chemicals company?
The median Debt-to-EBITDA among Chemicals companies is 2.14, based on 1,243 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Vital Chemtech's current Debt-to-EBITDA of 7.34 is 243% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-EBITDA mean?
A high Debt-to-EBITDA can signal that a stock is expensive relative to its fundamentals. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Vital Chemtech. For the Chemicals industry, the median Debt-to-EBITDA is 2.14 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vital Chemtech's current Debt-to-EBITDA is 7.34, which is 132% above median its own 10-year median of 3.17. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vital Chemtech stock overvalued right now?
Based on GuruFocus' analysis, Vital Chemtech (NSE:VITAL) is currently considered Possible Value Trap. The stock's GF Value™ is ₹83.08, compared to a current price of ₹54.50 — trading 34.4% below its estimated fair value. The current Debt-to-EBITDA is 7.34, which is 132% above median its 10-year median of 3.17 and 243% above the Chemicals industry median of 2.14. Vital Chemtech's overall GF Score™ is 76/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-EBITDA calculated?
Debt-to-EBITDA is calculated from a company's financial statements. For Vital Chemtech (NSE:VITAL), the current Debt-to-EBITDA is 7.34 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Vital Chemtech (NSE:VITAL) Overvalued in 2026?
Based on GuruFocus' analysis, Vital Chemtech stock appears to be undervalued.
The current stock price of ₹54.50 is trading 34.4% below its estimated GF Value™ of ₹83.08.
GuruFocus considers Vital Chemtech to be Possible Value Trap.
Key valuation signals for NSE:VITAL:
Debt-to-EBITDA: 7.34 (132% above median its 10-year median of 3.17)
GF Value™: ₹83.08 vs. price of ₹54.50 (34.4% below fair value)
Industry Position: 243% above the Chemicals median (#1059 of 1243)
No single metric tells the full story. See the NSE:VITAL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Vital Chemtech Ltd is engaged in the business of manufacturing, producing, refining, processing, formulating, mixing, enriching, mining, importing, exporting, acquiring, inventing, buying, selling, exchanging, distributing, and otherwise trading and dealing in all kinds of mixtures, formlations, intermediates, derivatives, compounds, phosphorous based chemicals, fine chemicals, heavy chemicals, valence, inorganic and organic chemicals, source materials, intermediates, ingredients, mixtures, derivatives and compounds. The company's Products include Phosphorus Derivatives, Industrial Chemicals, Specialty Chemicals & Intermediates, Organophosphates, Polymers & Dispersants, and Wellness Products.
76GF Score
Get the complete analysis for NSE:VITAL
Debt-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:VITAL has been successfully added to your 
